gazette | Ministry-of-Health-and-Family-Welfare | Department-of-Health-and-Family-Welfare

- Department of Health and Family Welfare

publication of Gazette Notification in part Il section 3 sub Section ii of the Gazette of India Extraordinary reg

Not Applicable--Part II-Section 3-Sub-Section (ii)-2021

2021-12-31

- Department of Health and Family Welfare

Final notification to amend rule 46 of the Medical Devices Rules 2017 in order to defer the date and manner of implementation of Unique Device Identification

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-12-31

- Department of Health and Family Welfare

Reconstitution of EPC under NHM MoHFW

Drugs Regulation Section--Part II-Section 3-Sub-Section (ii)-2021

2021-12-28

- Department of Health and Family Welfare

Amendment of rules 46 of the Medical Devices Rules 2017 to defer the date of implementation of UDI

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-12-23

- Department of Health and Family Welfare

Renotification of NIB Noida as CDL for testing and lot release of COVID 19 vaccine

Drugs Regulation Section--Part II-Section 3-Sub-Section (ii)-2021

2021-12-13

- Department of Health and Family Welfare

Publication of Gazette Notification in Part II Section 3 Sub Section ii of the Gazette of India Extraordinary reg

Not Applicable--Part II-Section 3-Sub-Section (ii)-2021

2021-12-13

- Department of Health and Family Welfare

Amendment of rule 36(3) of the Medical Devices Rules 2017 to include united kingdom

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-12-10

- Department of Health and Family Welfare

Amendment of rule 43A of the Drugs Rules 1945 to include ICD Tihi Indore for import of drug

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-12-09

- Department of Health and Family Welfare

Amendment of rule 24 and 24A of the Drugs Rules 1945 to omit provisions for issuing duplicate copy of the Import licence and Registration certificate

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-11-29

- Department of Health and Family Welfare

Amendment of rule 127 of the Drugs Rules 1945 for adding allura red in coal tar colour

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-11-29

- Department of Health and Family Welfare

Recruitment rules of National Medical Commission

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-11-29

- Department of Health and Family Welfare

Constitution of State Allied and Healthcare Councils under the National Commission for Allied and Healthcare Professions Act 2021

Drugs Regulation Section--Part II-Section 3-Sub-Section (ii)-2021

2021-11-25

- Department of Health and Family Welfare

Delegation of Powers to CEO NHA

NATIONAL HEALTH AUTHORITY--Part I-Section 1-2021

2021-11-22

- Department of Health and Family Welfare

Notification regarding designation of Director Deputy Secretary Tobacco Control as the nodal officer under the Information Technology Intermediary guidelines and Digital Media Ethics Code Rules 2021 referred as IT Rules 2021 under the IT Act 2000 for exercising the powers under Rule 3 1 d of the said Rules in context of enforcing the provisions of ban on advertising under COTPA for tobacco products and under the Prohibition of electronic cigarettes Act for e cigarettes on online platforms

National Tobacco Control Programme (NTCP)--Part II-Section 3-Sub-Section (ii)-2021

2021-11-15

- Department of Health and Family Welfare

Implementation date for provision of clause 2 of Explanation of Section 22 of the FSSA 2006

Drugs Regulation Section--Part II-Section 3-Sub-Section (ii)-2021

2021-11-03

- Department of Health and Family Welfare

Amendment of the New Drugs and Clinical Trials Rules 2019 to include cell stem cell derived product in place of stem cell derived product

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-10-27

- Department of Health and Family Welfare

Amendment of the Drugs Rules to specify timelines of 7 working days for issuance of Test License.

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-10-27

- Department of Health and Family Welfare

To allow import of Oxytocin API for manufacture of formulation for export purpose only

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-10-27

- Department of Health and Family Welfare

Reconstitution of DTAB

Drugs Regulation Section--Part II-Section 3-Sub-Section (ii)-2021

2021-10-18

- Department of Health and Family Welfare

Medical Termination of Pregnancy Rules 2003

Drugs Regulation Section--Part II-Section 3-Sub-Section (i)-2021

2021-10-12

Data Coverage

Doc Type

Ministry

Department

Year

Year

publication of Gazette Notification in part Il section 3 sub Section ii of the Gazette of India Extraordinary reg

Final notification to amend rule 46 of the Medical Devices Rules 2017 in order to defer the date and manner of implementation of Unique Device Identification

Reconstitution of EPC under NHM MoHFW

Amendment of rules 46 of the Medical Devices Rules 2017 to defer the date of implementation of UDI

Renotification of NIB Noida as CDL for testing and lot release of COVID 19 vaccine

Publication of Gazette Notification in Part II Section 3 Sub Section ii of the Gazette of India Extraordinary reg

Amendment of rule 36(3) of the Medical Devices Rules 2017 to include united kingdom

Amendment of rule 43A of the Drugs Rules 1945 to include ICD Tihi Indore for import of drug

Amendment of rule 24 and 24A of the Drugs Rules 1945 to omit provisions for issuing duplicate copy of the Import licence and Registration certificate

Amendment of rule 127 of the Drugs Rules 1945 for adding allura red in coal tar colour

Recruitment rules of National Medical Commission

Constitution of State Allied and Healthcare Councils under the National Commission for Allied and Healthcare Professions Act 2021

Delegation of Powers to CEO NHA

Implementation date for provision of clause 2 of Explanation of Section 22 of the FSSA 2006

Amendment of the New Drugs and Clinical Trials Rules 2019 to include cell stem cell derived product in place of stem cell derived product

Amendment of the Drugs Rules to specify timelines of 7 working days for issuance of Test License.

To allow import of Oxytocin API for manufacture of formulation for export purpose only

Reconstitution of DTAB

Medical Termination of Pregnancy Rules 2003